Pierpoint Capital

Managing Partner Amir Abolfathi leads the firm. The broader partner group — thirteen named individuals — includes former CEOs and senior operators from medical-device and healthcare companies, but the firm's website does not specify an investment committee structure or detailed governance process.

The firm leans heavily on its partner network of former medical-device founders and senior healthcare executives. This operator-first model likely surfaces opportunities through clinical and industry relationships rather than through conventional auction processes, though the firm has not publicly detailed its origination strategy.

Pierpoint Capital is structured as a traditional growth-equity firm and asset manager, not a family office. It is based at 45 Rockefeller Plaza and operates as Pierpoint Capital LLC, with a partner roster drawn from the healthcare and medtech C-suite.

The firm describes itself as investing in and launching category leaders, which implies both direct growth-equity investments in existing companies and new company creation — a model akin to a venture studio or company builder. It has not publicly disclosed whether it makes fund-of-fund commitments or participates as a limited partner in external vehicles.

The firm's entire partner roster is drawn from healthcare, medical devices, and health technology. Sectors represented in partners' operating histories include cardiac and vascular devices, digital health platforms, healthcare services, and hospital systems. No non-healthcare verticals are evident.